Yüklüyor......
A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening
INTRODUCTION: Clinical decision-making in the setting of CT screening could benefit from accessible biomarkers that help predict the level of lung cancer risk in high-risk individuals with indeterminate pulmonary nodules. METHODS: To identify candidate serum biomarkers, we measured 70 cancer-related...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3308353/ https://ncbi.nlm.nih.gov/pubmed/22425918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31824ab6b0 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|